
### [NCIT:C3326](http://purl.obolibrary.org/obo/NCIT_C3326)
**Label:** Adrenal Gland Pheochromocytoma

**Subclasses:** [NCIT:C27279](http://purl.obolibrary.org/obo/NCIT_C27279) (Localized Adrenal Gland Pheochromocytoma), [NCIT:C4220](http://purl.obolibrary.org/obo/NCIT_C4220) (Malignant Adrenal Gland Pheochromocytoma), [NCIT:C48305](http://purl.obolibrary.org/obo/NCIT_C48305) (Benign Adrenal Gland Pheochromocytoma), [NCIT:C118822](http://purl.obolibrary.org/obo/NCIT_C118822) (Childhood Adrenal Gland Pheochromocytoma), [NCIT:C8047](http://purl.obolibrary.org/obo/NCIT_C8047) (Recurrent Adrenal Gland Pheochromocytoma), [NCIT:C8045](http://purl.obolibrary.org/obo/NCIT_C8045) (Regional Adrenal Gland Pheochromocytoma), [NCIT:C92184](http://purl.obolibrary.org/obo/NCIT_C92184) (Malignant Adrenal Gland Composite Pheochromocytoma), [NCIT:C8046](http://purl.obolibrary.org/obo/NCIT_C8046) (Metastatic Adrenal Gland Pheochromocytoma), [NCIT:C92181](http://purl.obolibrary.org/obo/NCIT_C92181) (Benign Adrenal Gland Composite Pheochromocytoma), [NCIT:C48306](http://purl.obolibrary.org/obo/NCIT_C48306) (Adrenal Gland Composite Pheochromocytoma), 

**Class expressions from DL-Learner:**

- [NCIT:C48560](http://purl.obolibrary.org/obo/NCIT_C48560) (Malignant Chromaffin Cell) 58.33%
- [NCIT:C37151](http://purl.obolibrary.org/obo/NCIT_C37151) (Neoplastic Schwann Cell) 58.33%
- [NCIT:C37145](http://purl.obolibrary.org/obo/NCIT_C37145) (Neoplastic Neuroblast) 58.33%
- [NCIT:C36929](http://purl.obolibrary.org/obo/NCIT_C36929) (Malignant Endocrine Cell) and [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 58.33%
- [NCIT:C36825](http://purl.obolibrary.org/obo/NCIT_C36825) (Malignant Neuroendocrine Cell) and [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 58.33%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 58.33%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 58.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 58.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 58.33%
- Thing 52.49%
- [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) 43.69%
- [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) and (not ([NCIT:C36593](http://purl.obolibrary.org/obo/NCIT_C36593) (Increased NFkappaB Pathway Activation))) 43.69%
- [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) and (not ([NCIT:C36592](http://purl.obolibrary.org/obo/NCIT_C36592) (Gain of Chromosome 9q34))) 43.69%
- [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) and (not ([NCIT:C36591](http://purl.obolibrary.org/obo/NCIT_C36591) (t(X;2)(q11-12;p23)))) 43.69%
- [NCIT:C48559](http://purl.obolibrary.org/obo/NCIT_C48559) (Neoplastic Chromaffin Cell) and (not ([NCIT:C36590](http://purl.obolibrary.org/obo/NCIT_C36590) (t(2;17)(p23;q23)))) 43.69%


